699 related articles for article (PubMed ID: 33128201)
1. Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study.
Grellmann C; Dombrowsky W; Fabricius V; Suruki R; Sheahan A; Joeres L
Adv Ther; 2021 Jan; 38(1):366-385. PubMed ID: 33128201
[TBL] [Abstract][Full Text] [Related]
2. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
Loganathan A; Kamalaraj N; El-Haddad C; Pile K
Int J Rheum Dis; 2021 Sep; 24(9):1112-1120. PubMed ID: 34076348
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.
Nas K; Karkucak M; Durmus B; Karatay S; Capkın E; Kaya A; Ucmak D; Akar ZA; Cevik R; Kilic E; Kilic G; Ozgocmen S
Int J Rheum Dis; 2015 Nov; 18(8):873-9. PubMed ID: 26173043
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Solomon DH; Love TJ; Canning C; Schneeweiss S
Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
[TBL] [Abstract][Full Text] [Related]
6. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
7. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies.
Meer E; Thrastardottir T; Wang X; Dubreuil M; Chen Y; Gelfand JM; Love TJ; Ogdie A
J Rheumatol; 2022 Jan; 49(1):53-59. PubMed ID: 34334358
[TBL] [Abstract][Full Text] [Related]
10. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
11. Quantification of hand muscle volume and composition in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Friedberger A; Figueiredo C; Grimm A; d'Oliveira I; Bäuerle T; Rech J; Kleyer A; Simon D; Uder M; Schett G; Engelke K
BMC Musculoskelet Disord; 2020 Apr; 21(1):203. PubMed ID: 32241261
[TBL] [Abstract][Full Text] [Related]
12. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
Skornicki M; Prince P; Suruki R; Lee E; Louder A
Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
[TBL] [Abstract][Full Text] [Related]
13. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
Feldman SR; Zhao Y; Shi L; Tran MH; Lu J
Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
Stouten V; Pazmino S; Verschueren P; Mamouris P; Westhovens R; de Vlam K; Bertrand D; Van der Elst K; Vaes B; De Cock D
RMD Open; 2021 Jun; 7(2):. PubMed ID: 34158353
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
[TBL] [Abstract][Full Text] [Related]
16. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
[TBL] [Abstract][Full Text] [Related]
18. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.
Curtis JR; Mariette X; Gaujoux-Viala C; Blauvelt A; Kvien TK; Sandborn WJ; Winthrop K; de Longueville M; Huybrechts I; Bykerk VP
RMD Open; 2019; 5(1):e000942. PubMed ID: 31245056
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
Su YJ
Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]